Stock Analysis on Net
Stock Analysis on Net

Celgene Corp. (NASDAQ:CELG)

This company has been moved to the archive! The financial data has not been updated since October 31, 2019.

Total Asset Turnover 
since 2005

Microsoft Excel

Calculation

Celgene Corp., total asset turnover, long-term trends, calculation

Microsoft Excel
Total asset turnover = Net product sales1 ÷ Total assets1
Dec 31, 2018 0.43 = 15,265 ÷ 35,480
Dec 31, 2017 0.43 = 12,973 ÷ 30,141
Dec 31, 2016 0.40 = 11,185 ÷ 28,086
Dec 31, 2015 0.34 = 9,161 ÷ 27,053
Dec 31, 2014 0.44 = 7,564 ÷ 17,340
Dec 31, 2013 0.48 = 6,362 ÷ 13,378
Dec 31, 2012 0.46 = 5,386 ÷ 11,734
Dec 31, 2011 0.47 = 4,700 ÷ 10,006
Dec 31, 2010 0.34 = 3,508 ÷ 10,177
Dec 31, 2009 0.48 = 2,567 ÷ 5,389
Dec 31, 2008 0.48 = 2,138 ÷ 4,445
Dec 31, 2007 0.36 = 1,300 ÷ 3,611
Dec 31, 2006 0.30 = 812 ÷ 2,736
Dec 31, 2005 0.36 = 446 ÷ 1,247

Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in millions

Comparison to Competitors

Celgene Corp., total asset turnover, long-term trends, comparison to competitors

Microsoft Excel
Celgene Corp. AbbVie Inc. Amgen Inc. Bristol-Myers Squibb Co. Danaher Corp. Eli Lilly & Co. Gilead Sciences Inc. Johnson & Johnson Merck & Co. Inc. Moderna Inc. Pfizer Inc. Regeneron Pharmaceuticals Inc. Thermo Fisher Scientific Inc.
Dec 31, 2018 0.43 0.55 0.34 0.64 0.42 0.56 0.34 0.53 0.51 0.00 0.34 0.57 0.43
Dec 31, 2017 0.43 0.40 0.27 0.62 0.39 0.51 0.37 0.49 0.46 — 0.31 0.67 0.37
Dec 31, 2016 0.40 0.39 0.28 0.58 0.37 0.55 0.53 0.51 0.42 — 0.31 0.70 0.40
Dec 31, 2015 0.34 0.43 0.29 0.52 0.43 0.56 0.62 0.53 0.39 — 0.29 0.73 0.41
Dec 31, 2014 0.44 0.72 0.28 0.47 0.54 0.53 0.71 0.57 0.43 — 0.29 0.73 0.39
Dec 31, 2013 0.48 0.64 0.28 0.42 0.55 0.66 0.48 0.54 0.42 — 0.30 0.71 0.41
Dec 31, 2012 0.46 0.68 0.31 0.49 0.55 0.66 0.44 0.55 0.45 — 0.32 0.66 0.46
Dec 31, 2011 0.47 — 0.31 0.64 0.54 0.72 0.47 0.57 0.46 — 0.36 0.34 0.44
Dec 31, 2010 0.34 — 0.34 0.63 0.59 0.74 0.64 0.60 0.43 — 0.35 0.42 0.51
Dec 31, 2009 0.48 — 0.36 0.61 0.57 0.80 0.67 0.65 0.24 — 0.23 0.51 0.47
Dec 31, 2008 0.48 — 0.40 0.70 0.73 0.70 0.72 0.75 0.51 — 0.43 0.36 0.50
Dec 31, 2007 0.36 — 0.41 0.74 0.63 0.70 0.64 0.75 0.50 — 0.42 0.13 0.46
Dec 31, 2006 0.30 — 0.41 0.70 0.75 0.71 0.63 0.76 0.51 — 0.42 0.11 0.18
Dec 31, 2005 0.36 — 0.41 0.68 0.87 0.60 0.48 0.87 0.49 — 0.44 0.16 0.62

Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

Celgene Corp., total asset turnover, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel
Celgene Corp. Pharmaceuticals, Biotechnology & Life Sciences
Dec 31, 2018 0.43 0.45
Dec 31, 2017 0.43 0.40
Dec 31, 2016 0.40 0.41
Dec 31, 2015 0.34 0.42
Dec 31, 2014 0.44 0.45
Dec 31, 2013 0.48 0.43
Dec 31, 2012 0.46 0.45
Dec 31, 2011 0.47 0.46
Dec 31, 2010 0.34 0.47
Dec 31, 2009 0.48 0.39
Dec 31, 2008 0.48 0.57
Dec 31, 2007 0.36 0.56
Dec 31, 2006 0.30 0.54
Dec 31, 2005 0.36 0.57

Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Industry (Health Care)

Celgene Corp., total asset turnover, long-term trends, comparison to industry (health care)

Microsoft Excel
Celgene Corp. Health Care
Dec 31, 2018 0.43 0.67
Dec 31, 2017 0.43 0.68
Dec 31, 2016 0.40 0.70
Dec 31, 2015 0.34 0.67
Dec 31, 2014 0.44 0.72
Dec 31, 2013 0.48 0.69
Dec 31, 2012 0.46 0.69
Dec 31, 2011 0.47 0.70
Dec 31, 2010 0.34 0.69
Dec 31, 2009 0.48 0.64
Dec 31, 2008 0.48 0.81
Dec 31, 2007 0.36 0.77
Dec 31, 2006 0.30 0.74
Dec 31, 2005 0.36 0.70

Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).